Generally, IL-2 [37,38], IFN-gamma [39], IFN-alpha [40], and TNF-alpha signaling [41] can elicit a pro-inflammatory response and demonstrate potent anti-tumor effects in CRC through a direct and indirect mechanism. The gene discussed is TNF; the disease is colorectal carcinoma.